575 related articles for article (PubMed ID: 17593640)
1. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
3. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
[TBL] [Abstract][Full Text] [Related]
6. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
Galić J; Simunović D
Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
8. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
[TBL] [Abstract][Full Text] [Related]
9. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
11. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
12. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
Boyle P
Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
Dehghani M; Mostafavi-Pour Z; Lotfi M; Shakeri S
Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378
[TBL] [Abstract][Full Text] [Related]
14. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
[TBL] [Abstract][Full Text] [Related]
15. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
Madersbacher S
Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
[TBL] [Abstract][Full Text] [Related]
16. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Cricelli C; Brenes F; Pedromingo-Marino A; Castro R
Int J Clin Pract; 2009 Aug; 63(8):1192-7. PubMed ID: 19558487
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
[TBL] [Abstract][Full Text] [Related]
18. [General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany].
Coeurdacier P; Staerman F; Thoquenne G; Cipolla B; Guillé F; Lobel B
Prog Urol; 1996 Feb; 6(1):52-9. PubMed ID: 8624528
[TBL] [Abstract][Full Text] [Related]
19. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
Klomp ML; Rosmalen CF; Romeijnders AC; Oosterhof GO; Schlatmann TJ
Ned Tijdschr Geneeskd; 1998 Nov; 142(47):2563-8. PubMed ID: 10028352
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]